P, V., CH, C., A, I., X, Z., W, A., R, F., . . . LR, S. (2021). Rova-T enhances the anti-tumor activity of anti-PD1 in a murine model of small cell lung cancer with endogenous Dll3 expression. Translational oncology, 14(1), 100883. https://doi.org/10.1016/j.tranon.2020.100883
Chicago Style (17th ed.) CitationP, Vitorino, et al. "Rova-T Enhances the Anti-tumor Activity of Anti-PD1 in a Murine Model of Small Cell Lung Cancer with Endogenous Dll3 Expression." Translational Oncology 14, no. 1 (2021): 100883. https://doi.org/10.1016/j.tranon.2020.100883.
MLA (9th ed.) CitationP, Vitorino, et al. "Rova-T Enhances the Anti-tumor Activity of Anti-PD1 in a Murine Model of Small Cell Lung Cancer with Endogenous Dll3 Expression." Translational Oncology, vol. 14, no. 1, 2021, p. 100883, https://doi.org/10.1016/j.tranon.2020.100883.